CN Patent
CN106083830B — 双吲哚马来酰亚胺衍生物及其制备方法和用途
Assigned to Guizhou Natural Products Research Center · Expires 2019-07-12 · 7y expired
What this patent protects
提供一种双吲哚马来酰亚胺衍生物及其制备方法和用途。所述双吲哚马来酰亚胺衍生物具有良好的肿瘤治疗作用,特别是对一些耐药肿瘤的疗效,能够实现对这些耐药肿瘤的精确治疗。
USPTO Abstract
提供一种双吲哚马来酰亚胺衍生物及其制备方法和用途。所述双吲哚马来酰亚胺衍生物具有良好的肿瘤治疗作用,特别是对一些耐药肿瘤的疗效,能够实现对这些耐药肿瘤的精确治疗。
Drugs covered by this patent
- Rydapt (MIDOSTAURIN) · Novartis
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.